Apr 26, 2024

Public workspaceFluorescence assay for MERS-CoV Mpro activity measurement

  • 1Center for Medicines Discovery, University of Oxford
Open access
Protocol CitationCharline Giroud, oleg.fedorov 2024. Fluorescence assay for MERS-CoV Mpro activity measurement. protocols.io https://dx.doi.org/10.17504/protocols.io.8epv5rzm4g1b/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: April 26, 2024
Last Modified: April 26, 2024
Protocol Integer ID: 98853
Keywords: FRET assay, enzymatic assay, viral proteases, Coronavirus
Funders Acknowledgement:
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
Grant ID: U19AI171399
Disclaimer
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Abstract
This protocol details the fluorescence assay for MERS-CoV Mpro protease activity measurement. This method is intended to measure the activity of viral proteases by using a specific labelled peptide that allows the detection of the cleaved product. The substrate contains the cleavage-sequence specific to the tested protease and is labeled in C-terminal by the fluorophore Edans (ex 336 nm; em: 455 nm) and in N-ternimal by the quencher Dabcyl (ex 472 nm). In the case of a non-cleaved substrate, the proximity of Dabcyl to Edans prevents the emission and the detection of the fluorescence at 455 nm. The cleavage of the peptide by the protease allows Edans’ fluorescence emission and detection.
Attachments
Materials
Reagents

  • Assay buffer:

AB
Tris pH 7.050 mM
NaCl150 mM
Glycerol10%
DTT (optional)0.5 mM

  • Incubation: Duration01:00:00 at TemperatureRoom temperature .

  • EV-D68 3C: Protein stocks were stored at Temperature-80 °C and used as 2x solution (Concentration1 micromolar (µM) , Concentration0.5 micromolar (µM) final assay concentration) in assay buffer.

  • Substrate: Dabcyl-KEALFQGPPQFE-Edans (LifeTein, USA) prepared as a stock solution at Concentration5 millimolar (mM) in DMSO and used at 2x solution (Concentration40 micromolar (µM) , Concentration20 micromolar (µM) final concentration assay concentration) in assay buffer.

  • Positive control: GC376 (Pubchem CID 71481119), Concentration50 micromolar (µM) top final assay concentration.

  • Plates: ProxiPlate-384 Plus, white, Greiner cat# 6008280.

  • Liquid handler: Echo® acoustic liquid handler (Beckman Coulter, USA).

  • Plate reader: Pherastar FS, BMG Labtech (Germany), 350-460 FI optic module, the plate is read every 30 s for 2 hours and shacked during 5 s before the first reading.


MERS-CoV Mpro Assay
MERS-CoV Mpro Assay
3h
This method is intended to measure the activity of viral proteases by using a specific labelled-peptide that allows the detection of the cleaved product. The substrate contains the cleavage-sequence specific to the tested protease and is labeled in C-terminal by the fluorophore Edans (ex 336 nm; em: 455 nm) and in N-ternimal by the quencher Dabcyl (ex 472 nm). In the case of a non-cleaved substrate, the proximity of Dabcyl to Edans prevents the emission and the detection of the fluorescence at 455 nm. The cleavage of the peptide by the protease allows Edans’ fluorescence emission and detection.
Screenshot 2024-04-25 162114.png
Asset URL:

Reagents and equipment
Reagents and equipment
Assay buffer: Concentration50 millimolar (mM) Tris pH 7.0, Concentration150 millimolar (mM) NaCl, Concentration10 % (v/v) glycerol and Concentration1 millimolar (mM) TCEP (optional). Incubation: Duration01:00:00 at room temperature. MERS-MPro: protein stocks were stored at -80C and used as Concentration2 Mass Percent solution (Concentration1.2 micromolar (µM) , Concentration0.6 micromolar (µM) final assay concentration) in assay buffer.
Positive control: Ebselen (Pubchem CID 3194), Concentration50 micromolar (µM) top final assay concentration. Substrate: Edans-GVLQSGLV-LysDabcyl-K (LifeTein, USA) prepared as a stock solution at 10 mM in DMSO and used at 2x solution (Concentration20 micromolar (µM) , Concentration10 micromolar (µM) final concentration assay concentration) in assay buffer. Liquid handler: Echo acoustic liquid handler (Beckman Coulter, USA). Plate reader: Pherastar FS, BMG Labtech (Germany), 350-460 FI optic module, the plate is read every Duration00:00:30 for Duration02:00:00 and shacked Duration00:00:05 before each reading.
3h 0m 35s
MERS-MPro IC50 Measurement
MERS-MPro IC50 Measurement
3h
Add Amount50 µL of 2x protein Concentration1.2 micromolar (µM) solution to each well containing the compounds to be tested previously dispensed onto the plate.

Pipetting
Incubate the mix for Duration01:00:00 at TemperatureRoom temperature to initiate the enzymatic reaction by the addition of Amount50 µL of 2x (Concentration20 micromolar (µM) ) substrate solution using the plate reader injector.

1h
Incubation
Read the fluorescence intensity at 350/460 nm every Duration00:00:30 for Duration00:00:30 in kinetic mode, which includes a shaking step of the plate before each measurement.

1m
Calculate the IC50 by plotting the initial velocity against various concentrations of tested inhibitors by using a four-parameter dose−response curve in Prism (v8.0) software.
Screenshot 2024-04-12 103108.png
Asset URL:

Calculate the mean (μ) and the standard deviation (σ) of fluorescence intensity and then calculate the signal-to-background ratio and the Z' or Zfactor. (s: signal; c: control).Screenshot 2024-03-18 100008.png
Asset URL: